Z

Zura Bio Limited
D

ZURA

3.40500
USD
-0.28
(-7.47%)
مغلق
حجم التداول
155,899
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
323,068,818
المقالات
المزيد

العنوان: Zura Bio Limited

القطاع: Healthcare
الصناعة: Biotechnology
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.